MYC and hematologic disorder: Bmal1 is a key component in hematologic malignancies, and the inactivation of BMAL1 promotes the progression of hematologic malignancies by disrupting the cellular circadian rhythm and impairing the characteristic circadian clock expression pattern of genes, including C-MYC, catalase, and p300 [60].